Eradication of Helicobacter pylori, which is associated with diverse gastroduodenal pathologies of varying severity, is sometimes challenging. We conducted a prospective study to determine the effect of tonsillectomy on the eradication of H pylori from the gastrointestinal tract. Our study population was made up of 46 patients-32 females and 14 males, aged 14 to 58 years (mean: 28.84 ± 9.65)-who had chronic tonsillitis and concomitant dyspepsia. An initial gastrointestinal endoscopy was performed to obtain specimens for histology and a rapid urease test. These gastroscopies revealed that 32 patients were H pylori-positive (69.6%) and 14 were H pylorinegative (30.4%); these groups were designated A and B, respectively. The 32 H pylori-positive patients were divided into three subgroups based on the sequence in which they underwent drug therapy and tonsillectomy. All 3 subgroups received the same 14-day combination-drug regimen for eradication of gastric H pylori. The patients in group A1 (n = 12) underwent tonsillectomy prior to receiving drug treatment; 2 months after the cessation of drug therapy, they underwent a second gastroscopy. The patients in group A2 (n = 10) received drug treatment first followed by tonsillectomy; 2 months later, they underwent their second gastroscopy. The patients in group A3 (n = 10) received drug treatment first, then they underwent a second gastroscopy, and then they were taken for tonsillectomy. The success or failure of H pylori eradication was determined by the second gastroscopy. Also, analyses were performed after tonsillectomy to look for H pylori infection in tonsillar specimens. Eradication of gastric H pylori was achieved in 9 of the 12 group A1 patients (75.0%), 8 of the 10 group A2 patients (80.0%), and 7 of the 10 group A3 patients (70.0%); there were no statistically significant differences among the three groups. Likewise, there were no significant differences between any subgroups or combination of subgroups in terms of tonsillar positivity. As far as we know, this is the first study to investigate the effect of tonsillectomy on the outcome of H pylori eradication treatment. In light of our findings, we may speculate that tonsillar tissue does not seem to be a reservoir for H pylori infection. Although tonsillectomy had no significant effect on gastric H pylori eradication in our study, our results might have been skewed by the relatively small size of our sample.
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Introduction
The treatment of various gastroduodenal diseases has changed greatly since the early 1980s when Marshall and Warren isolated a Campylobacter-like organism in the stomachs of patients with gastritis and peptic ulcer disease. 1 Thereafter, gastrointestinal diseases for which only symptomatic treatment had been available were being cured by the eradication of the newly discovered bacterium. 2 Since then, the name of this organism has changed from Campylobacter pylori to Helicobacter pylori.
Although H pylori infection is one of the most com-mon infections worldwide, its mode of transmission is still not fully understood. 3 Studies have shown that extragastric sites of H pylori infection include the nasal cavity and sinus mucous membranes, 4,5 dental plaques, 6 oral lesions, 7 saliva, 8 and tonsillar and adenoid tissues. [9] [10] [11] [12] However, some studies investigating the tonsils as a potential reservoir for H pylori infection have yielded a wide variety of findings, with positivity rates ranging from 0 to 57%. 9, 10, [13] [14] [15] Minocha et al reported that a history of tonsillectomy was associated with a decreased risk of H pylori infection, 16 and it is still commonly believed that the existence of H pylori in the oral cavity might be responsible for reinfection. 7, 17, 18 In this article, we describe our study to clarify whether tonsillectomy has any effect on the eradication of gastric H pylori infection.
Patients and methods
We prospectively studied 46 patients with chronic tonsillitis and dyspepsia who were admitted to the Department of Otolaryngology-Head and Neck Surgery at Dr. Lutfi Kirdar Kartal Education and Research Hospital in Istanbul between Nov. 1, 2002, and Feb. 29, 2004 . This group was made up of 32 females and 14 males, aged 14 to 58 years (mean: 28.84 ± 9.65).
Our exclusion criteria were (1) previous gastric surgery, (2) previous H pylori eradication treatment, (3) consumption of antibiotics during the previous month, and (4) consumption of antisecretory drugs, bismuth salts, or sucralfate during the previous 2 weeks. A history of bleeding and coagulation disorders was also a reason for exclusion.
All patients underwent an initial upper gastrointestinal endoscopy in the Department of Gastroenterology at the Istanbul University Cerrahpasa Faculty of Medicine. Three antrum and two corpus biopsies were obtained from each patient for histology (two antrum and one corpus specimen) and for rapid urease testing (one antrum and one corpus specimen). Biopsy specimens were placed in a Campylobacter-like organism (CLO) test (Tri-Med; Osborne Park, Australia), maintained at room temperature, and read at 1 hour and at 24 hours after sampling.
The specimens were processed for histologic examination according to standard procedures. Hematoxylin and eosin (H&E) staining, as well as special staining for H pylori (Giemsa), were performed. All biopsy samples were examined by the same pathologist, who specialized in digestive diseases. A patient was classified as being H pylori-positive if both the histologic analysis and the rapid urease test result were positive. Any patient with a conflicting result would have been excluded from the study.
The results of the first gastroscopy revealed that 32 of the 46 patients were H pylori-positive (69.6%) and 14 were H pylori-negative (30.4%); these groups were designated A and B, respectively. There were no statistically significant differences between these two groups in terms of age and sex (table 1) .
All patients in group A were given the same drug therapy aimed at eradicating their gastric H pylori. The regimen consisted of lansoprazole 30 mg twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1,000 mg twice daily for 14 days. These patients were divided into three subgroups based on the sequence in which they underwent drug therapy and tonsillectomy (figure). 
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The patients in group A1 (n = 12) underwent tonsillectomy prior to receiving drug treatment; 2 months after the cessation of drug therapy, they underwent a second gastroscopy. The patients in group A2 (n = 10) received drug treatment first followed by tonsillectomy; 2 months post-tonsillectomy, they underwent their second gastroscopy. The patients in group A3 (n = 10) received drug treatment first, then they underwent their second gastroscopy, and then they were taken for tonsillectomy. The success or failure of H pylori eradication from the gastrointestinal tract was determined by the second gastroscopy. All the patients in group B underwent tonsillectomy without the need for any other therapy.
In addition, tonsillar biopsies were performed on all 46 patients. Three 5 × 5-mm samples were obtained from each removed tonsil. One of the three samples was processed for histologic examination and the other two were washed with saline solution in sterile conditions and submitted to CLO testing. The results of the tonsillar biopsies were interpreted according to the same standards that were applied to the gastric biopsies.
Statistical analysis of parametric nonrepeated measures was performed with the Student t test, and analysis of nonparametric nonrepeated and repeated measures was performed with the Fisher exact test and the chisquare (χ 2 ) test. A p value of <0.05 was regarded as statistically significant. Calculations were performed with the Statistical Package for the Social Sciences software (SPSS; v. 11.0; Chicago).
The study protocol was approved by the ethics committee of our hospital, and all patients provided written informed consent.
Results

Gastrointestinal infection. No significant differences
were noted in gastric eradication rates among the three H pylori-positive groups. Eradication by drug therapy was successful in 9 of the 12 patients in group A1 (75.0%), in 8 of the 10 in group A2 (80.0%), and in 7 of the 10 in group A3 (70.0%).
When analyzed according to the timing of tonsillectomy vis-à-vis the second gastroscopy, there was no significant difference in eradication rates between those who underwent tonsillectomy before their second gastroscopy (groups A1 and A2) and those who underwent tonsillectomy after their second gastroscopy (group A3) (table 2) .
Tonsillar infection. In all, the tonsillar specimens of 5 of the 46 patients (10.9%) tested positive for H pylori. These positive results occurred in 2 of the 12 patients in group A1 (16.7%), in 1 of the 10 patients in both group A2 and group A3 (10.0%), and in 1 of the 14 patients in group B (7.1%).
No significant difference in tonsillar positivity was observed between patients who underwent tonsillectomy before gastrointestinal drug therapy (group A1) and those who did not require any such drug therapy (group B) (table 3) . Similarly, there was no significant difference in tonsillar positivity according to the timing of tonsillectomy vis-à-vis drug therapy between those who underwent tonsillectomy before drug therapy (group A1) and those who underwent tonsillectomy after drug therapy (groups A2 and A3) (table 4).
Discussion
A strong association has been established between colonization of the gastric mucosa by H pylori and various benign and malignant gastroduodenal diseases, including chronic active gastritis, gastric ulceration, duodenal ulcer, gastric adenocarcinoma, and gastric lymphoma of mucosa-associated lymphoid tissue (MALT). 19 The World Health Organization and an International Agency for Research on Cancer consensus group stated in 1994 that there was sufficient epidemiologic and histologic evidence to classify H pylori as a definite carcinogen. 20 Infection with H pylori seems to be a major health problem, particularly in Turkey, a developing country. The reported prevalence of H pylori infection in Turkey is as high as 85%; most cases develop during early childhood. 21, 22 To the best of our knowledge, our study is the first to determine the effect of tonsillectomy on the eradication of gastric H pylori infection and to clarify any indirect relationship between this bacterium and tonsillar tissue. In our study, the tonsils of 5 of 46 patients (10.9%) tested positive for H pylori by CLO testing. However, if we exclude those patients who underwent tonsillectomy after they received drug therapy for gastric eradication (i.e., if we exclude groups A2 and A3), tonsillar specimens were positive in only 3 of 26 patients (11.5%) (groups A1 and B). Additionally, gastric eradication success rates were very similar among the different groups regardless of whether they had undergone gastrointestinal drug treatment before or after tonsillectomy.
In light of our findings, we may speculate that tonsillar tissue does not seem to be a potential reservoir for H pylori infection. Our findings support the important results obtained by Bitar et al, who reported that none of the tonsillar tissues that were positive for H pylori on rapid urease testing was found to be positive on polymerase chain reaction. 23 Indeed, their findings raise the question as to whether a positive tonsillar rapid urease test actually does indicate the presence of an H pylori infection.
An important limitation of our study is the relatively small number of patients we studied. We found it particularly difficult to find patients with chronic tonsillitis and dyspepsia who did not have a history of antibiotic use during the previous month.
In conclusion, the results of our study indicate that tonsillectomy does not play a major role in the eradication of gastric H pylori infection. However, further studies with larger samples are needed to establish conclusive evidence. 
